Evan Anderson, CEO & Board Member, Luma Therapeutics
Evan Anderson, CEO and Board Member of Luma Therapeutics, has 17 years of experience in early stage product and market development. He completed the Stanford Biodesign Fellowship in 2004 and was first manager of R&D and then distribution sales at Spiracur (acquired by Acelity).
From the Luma Therapeutics website:
We are a medical device company developing light therapies for the 40 million people in the US with inflammatory skin disorders. Luma Therapeutics was born when our CEO Evan Anderson found that he had psoriasis and discovered a way to treat himself effectively. He knew then that he wanted to develop similar treatments for the millions of other people suffering from skin disorders.
We work hard every day to help people get clear skin with easy to use, affordable therapies.
Our goal is to develop an at home treatment that will put psoriasis in remission for an extended period of time after only a few weeks of therapy.
Bob Wachter: Debating the Digital Divide
Dr. Ronald Dixon: The DNA of a Winning Organization
Dana Kanze: Double Standards in Your Industry
Jeremiah Robison: The Amazing Electrical System
C.K. Wang: Data For the Real World
Sonia Arrison: Who Wants to Live Forever?
Suzanne Barakat: Documents of Unfathomable Trauma
Ofer Leidner: Mind Matters
Maria Velissaris: Investing in the Future
Andrew Parker: Business is Personal
Sachin Jain: Asking the Hard Questions
Tyler Shultz: More Than a Whistleblower
Dan Riskin: Leading with Authenticity
Andy Doraiswamy: Moving the Needle
Steve Wigginton: The Leadership Baseline
Nancy Lurker: Getting Out There
Adrienne Schneider: Reputation is Everything
Nicholas Conn: The Seat of Power
Kimberly Smith: Good Trouble
Catalina Hoffman: Fighting the Nos
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
NABOR® TALKS
U.S Property Podcast
Aligned Money Show
The Ramsey Show
Planet Money